Investing Profile

Kevin Bitterman

InvestorVC

Partner at ATLAS VENTURE

atlasventure.comCambridge, Massachusetts
Photo of Kevin Bitterman, Partner at Atlas Venture

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Atlas Venture Partner
$10.0M - $50.0M
$25.0M
29
CompanyStageDateRound SizeTotal Raised
Curie Therapeutics
Series ADec 2021$75M
$75M
Co-investors: Dan Becker (Access Biotechnology)
Remix Therapeutics
Series ADec 2020$65M
$65M
Co-investors: Leon Chen (The Column Group), Kristina Burow (ARCH Venture Partners)
Akero Therapeutics
Series AJun 2018$65M
$65M
Co-investors: Aaron Royston (venBio)
Neuronetics
Series GJun 2017$15M
Series FApr 2015$34M
Series EMay 2011$30M
$110M
Co-investors: Liam Ratcliffe (Access Biotechnology), Gil Kliman (InterWest), Leslie Bottorff (GE Ventures)
Visterra
Series CJun 2016$23M
Series BOct 2014$30M
Series ADec 2013$8.1M
Series ANov 2012$26M
Seed RoundMay 2009$3.3M
$91M
Co-investors: Ling Wong (Sea Lane Ventures)
Kala Pharmaceuticals
Series CApr 2016$68M
Series BApr 2014$23M
Series AFeb 2013$12M
Private Equity RoundMar 2012$7.2M
$110M
Co-investors: Robert Tepper (Third Rock Ventures), Karen Wagner (Ysios Capital)
Pulmatrix
Post-IPO EquityJun 2015$10M
Series BAug 2011$14M
Series BNov 2009$30M
$54M
Co-investors: Dave Maki (Altitude Life Science Ventures (ALSV)), Richard Ulevitch (5am Ventures), Scott Rocklage (5am Ventures), Steven Gillis (ARCH Venture Partners)
Arsenal Medical
Venture RoundJun 2015$16M
Venture RoundMay 2010$10M
$26M
Co-investors: Carmichael Roberts (Breakthrough Energy Ventures)